165 related articles for article (PubMed ID: 26098902)
1. Mortality in Children with Optic Pathway Glioma Treated with Up-Front BB-SFOP Chemotherapy.
Rakotonjanahary J; De Carli E; Delion M; Kalifa C; Grill J; Doz F; Leblond P; Bertozzi AI; Rialland X;
PLoS One; 2015; 10(6):e0127676. PubMed ID: 26098902
[TBL] [Abstract][Full Text] [Related]
2. Long-term visual acuity in patients with optic pathway glioma treated during childhood with up-front BB-SFOP chemotherapy-Analysis of a French pediatric historical cohort.
Rakotonjanahary J; Gravier N; Lambron J; De Carli E; Toulgoat F; Delion M; Pellier I; Rialland X
PLoS One; 2019; 14(3):e0212107. PubMed ID: 30849081
[TBL] [Abstract][Full Text] [Related]
3. Optic glioma in children: a retrospective analysis of 101 cases.
Varan A; Batu A; Cila A; Soylemezoğlu F; Balcı S; Akalan N; Zorlu F; Akyüz C; Kutluk T; Büyükpamukçu M
Am J Clin Oncol; 2013 Jun; 36(3):287-92. PubMed ID: 22547006
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy for unresectable and recurrent intramedullary glial tumours in children. Brain Tumours Subcommittee of the French Society of Paediatric Oncology (SFOP).
Doireau V; Grill J; Zerah M; Lellouch-Tubiana A; Couanet D; Chastagner P; Marchal JC; Grignon Y; Chouffai Z; Kalifa C
Br J Cancer; 1999 Nov; 81(5):835-40. PubMed ID: 10555754
[TBL] [Abstract][Full Text] [Related]
5. Optic pathway hypothalamic gliomas in children under three years of age: the role of chemotherapy.
Silva MM; Goldman S; Keating G; Marymont MA; Kalapurakal J; Tomita T
Pediatr Neurosurg; 2000 Sep; 33(3):151-8. PubMed ID: 11096362
[TBL] [Abstract][Full Text] [Related]
6. Long-term visual outcome after chemotherapy for optic pathway glioma in children: Site and age are strongly predictive.
Dodgshun AJ; Elder JE; Hansford JR; Sullivan MJ
Cancer; 2015 Dec; 121(23):4190-6. PubMed ID: 26280460
[TBL] [Abstract][Full Text] [Related]
7. The effect of chemotherapy on optic pathway gliomas and their sub-components: A volumetric MR analysis study.
Shofty B; Mauda-Havakuk M; Weizman L; Constantini S; Ben-Bashat D; Dvir R; Pratt LT; Joskowicz L; Kesler A; Yalon M; Ravid L; Ben-Sira L
Pediatr Blood Cancer; 2015 Aug; 62(8):1353-9. PubMed ID: 25858021
[TBL] [Abstract][Full Text] [Related]
8. A pilot study using carboplatin, vincristine, and temozolomide in children with progressive/symptomatic low-grade glioma: a Children's Oncology Group study†.
Chintagumpala M; Eckel SP; Krailo M; Morris M; Adesina A; Packer R; Lau C; Gajjar A
Neuro Oncol; 2015 Aug; 17(8):1132-8. PubMed ID: 25854526
[TBL] [Abstract][Full Text] [Related]
9. Treatments for astrocytic tumors in children: current and emerging strategies.
Burzynski SR
Paediatr Drugs; 2006; 8(3):167-78. PubMed ID: 16774296
[TBL] [Abstract][Full Text] [Related]
10. Low-dose cisplatin-etoposide regimen for patients with optic pathway glioma: a report of four cases and literature review.
Cardellicchio S; Bacci G; Farina S; Genitori L; Massimino M; de Martino M; Caputo R; Sardi I
Neuropediatrics; 2014 Feb; 45(1):42-9. PubMed ID: 24272769
[TBL] [Abstract][Full Text] [Related]
11. Optic pathway gliomas in adolescence--time to challenge treatment choices?
Chong AL; Pole JD; Scheinemann K; Hukin J; Tabori U; Huang A; Bouffet E; Bartels U
Neuro Oncol; 2013 Mar; 15(3):391-400. PubMed ID: 23295772
[TBL] [Abstract][Full Text] [Related]
12. Long-term response in high-grade optic glioma treated with medically induced hypothyroidism and carboplatin: a case report and review of the literature.
Ashur-Fabian O; Blumenthal DT; Bakon M; Nass D; Davis PJ; Hercbergs A
Anticancer Drugs; 2013 Mar; 24(3):315-23. PubMed ID: 23348245
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Survival Prognosis for Children with Symptomatic Optic Pathway Gliomas Who Received Surgery.
Liu Y; Hao X; Liu W; Li C; Gong J; Ma Z; Tian Y
World Neurosurg; 2018 Jan; 109():e1-e15. PubMed ID: 28986229
[TBL] [Abstract][Full Text] [Related]
14. [Management of chiasmatic-hypothalamic gliomas in children: report of nine pediatric cases].
Akiyama H; Nakamizo S; Kawamura A; Nagashima T; Takeda H; Hasegawa D; Kosaka Y; Yoshida M
No Shinkei Geka; 2007 Nov; 35(11):1079-85. PubMed ID: 18044225
[TBL] [Abstract][Full Text] [Related]
15. Outcome of newly diagnosed high risk medulloblastoma treated with carboplatin, vincristine, cyclophosphamide and etoposide.
Sirachainan N; Pakakasama S; Anurathapan U; Hansasuta A; Dhanachai M; Khongkhatithum C; Jinawath A; Mahachoklertwattana P; Hongeng S
J Clin Neurosci; 2018 Oct; 56():139-142. PubMed ID: 29960842
[TBL] [Abstract][Full Text] [Related]
16. [Effect of bevacizumab in treatment of children with optic pathway glioma].
Wu WS; Liu JJ; Sun YL; DU SX; Li CD; Li M; Ren SQ; Zhang J; Gong XJ; Sun LM
Zhongguo Dang Dai Er Ke Za Zhi; 2019 Dec; 21(12):1193-1197. PubMed ID: 31874658
[TBL] [Abstract][Full Text] [Related]
17. Single agent carboplatin for pediatric low-grade glioma: A retrospective analysis shows equivalent efficacy to multiagent chemotherapy.
Dodgshun AJ; Maixner WJ; Heath JA; Sullivan MJ; Hansford JR
Int J Cancer; 2016 Jan; 138(2):481-8. PubMed ID: 26235348
[TBL] [Abstract][Full Text] [Related]
18. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
19. Combination chemotherapy using carboplatin (JM-8) and etoposide (JET therapy) for recurrent malignant gliomas: a phase II study.
Watanabe K; Kanaya H; Fujiyama Y; Kim P
Acta Neurochir (Wien); 2002 Dec; 144(12):1265-70; discussion 1270. PubMed ID: 12478337
[TBL] [Abstract][Full Text] [Related]
20. Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma.
Buckner JC; Shaw EG; Pugh SL; Chakravarti A; Gilbert MR; Barger GR; Coons S; Ricci P; Bullard D; Brown PD; Stelzer K; Brachman D; Suh JH; Schultz CJ; Bahary JP; Fisher BJ; Kim H; Murtha AD; Bell EH; Won M; Mehta MP; Curran WJ
N Engl J Med; 2016 Apr; 374(14):1344-55. PubMed ID: 27050206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
